Niruja Product Development And Healthcare Research Profile
Key Indicators
- Authorised Capital ₹ 4.80 Cr
as on 16-11-2024
- Paid Up Capital ₹ 4.80 Cr
as on 16-11-2024
- Company Age 17 Year, 7 Days
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2023)
- Ebitda
- Net Worth 17.12%
(FY 2023)
- Total Assets 1.26%
(FY 2023)
About Niruja Product Development And Healthcare Research
The Corporate was formerly known as Mims Hcg Oncology Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.80 Cr and a paid-up capital of Rs 4.80 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ramesh Bilimagga and Basavalinga Sadasivaiah serve as directors at the Company.
- CIN/LLPIN
U73100KA2007PTC044658
- Company No.
044658
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Dec 2007
- Date of AGM
25 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Niruja Product Development And Healthcare Research?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramesh Bilimagga  | Director | 30-Mar-2015 | Current |
| Basavalinga Sadasivaiah | Director | 01-Mar-2021 | Current |
Financial Performance and Corporate Structure Insights of Niruja Product Development And Healthcare Research.
Niruja Product Development And Healthcare Research Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 17.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Niruja Product Development And Healthcare Research?
In 2023, Niruja Product Development And Healthcare Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Gha Global Healthcare Academy Private LimitedActive 5 years 9 daysBasavalinga Sadasivaiah is a mutual person
Bacc Health Care Private LimitedActive 22 years 10 monthsBasavalinga Sadasivaiah is a mutual person
Suchirayu Health Care Solutions LimitedActive 13 years 11 monthsBasavalinga Sadasivaiah is a mutual person
International Stemcell Services LimitedActive 16 years 3 monthsBasavalinga Sadasivaiah is a mutual person
Healthcare Global Senthil Multi Specialty Hospitals Private LimitedActive 19 years 8 monthsRamesh Bilimagga and Basavalinga Sadasivaiah are mutual person
- Healthcare Global Enterprises LimitedActive 26 years 9 months
Basavalinga Sadasivaiah is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Niruja Product Development And Healthcare Research?
Unlock and access historical data on people associated with Niruja Product Development And Healthcare Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Niruja Product Development And Healthcare Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Niruja Product Development And Healthcare Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
